NFATC2 and neoplasm: With additional stable NFATc2 knockdown, tumor shrinkage was enhanced to 3.15 and 2.2 fold relative to respective vehicle controls (p<0.01) (Figure 4D), while tumor growth rate was also retarded (Figure 4—figure supplement 1B).